Telomerase activity is known to be absent from most normal and well-differentiated tissues, although being detectable in the vast majority of malignant tumors. An increasing number of reports demonstrate that telomerase may be activated in benign tumors, such as adenomas. We have investigated a series of normal and neoplastic thyroid tissues for the presence of telomerase activity. As expected, all normal thyroid tissues (n ϭ 20) had no display of telomerase activity. Amongst cancers, the incidence of telomerase activity varied with the histological subtypes. Telomerase activity was present in only 3/15 cases (20%) of papillary carcinomas. Telomerase activity was more frequently detected in follicular (4/6) and in undifferentiated (2/3) carcinomas. Unexpectedly, one case (1/12) of adenoma contained high levels of telomerase activity. Taken together, these results indicate that telomerase may play some role in the pathogenesis of thyroid tumors, in particular in follicular and undifferentiated carcinomas that are known to have the most aggressive behavior. (J Clin Endocrinol Metab 82: 4214 -4216, 1997) H UMAN telomerase is a ribonucleoprotein (1-3) that is thought to play a key role in cancer pathogenesis (3, 4). Thus, telomerase activity has been detected in most types of cancer cells and is not present in nonneoplastic tissues (4). The cancer specificity of telomerase activity has been discussed in the light of recent data that normal (activated) lymphocytes (5-7), nonmalignant lymphoblastoid cell lines (8), and cells from benign adenomas could activate their telomerase (9).
H UMAN telomerase is a ribonucleoprotein (1) (2) (3) that is thought to play a key role in cancer pathogenesis (3, 4) . Thus, telomerase activity has been detected in most types of cancer cells and is not present in nonneoplastic tissues (4) . The cancer specificity of telomerase activity has been discussed in the light of recent data that normal (activated) lymphocytes (5-7), nonmalignant lymphoblastoid cell lines (8) , and cells from benign adenomas could activate their telomerase (9) .
Thyroid carcinomas originating from the follicular epithelium are composed of three main groups with different histological and clinical features (10) . Among them, follicular and undifferentiated carcinomas are more agressive than papillary carcinomas. Because all these tumors have different pathogenesis and clinical behavior, we sought to determine the patterns of telomerase activity in a series of thyroid carcinomas.
Materials and Methods

Tissue samples
T cell leukemia CEM and Ishikawa cell lines (8) were used as positive controls for telomerase activity. Twenty samples of normal thyroid tissues and 12 adenomas, 15 papillary carcinomas, 6 follicular carcinomas, and 3 undifferentiated carcinomas were evaluated in this study. Tumors were classified according to the World Health Organization classification (10) . Adenomas were classified as follows: 6 cases of microfollicular, 4 cases of macrofollicular, and 2 cases of trabecular pattern. All cases of papillary carcinomas were thicker than 1 cm and 2 cases corresponded to a Hü rthle cell variant (10) . One of the 3 cases of undifferentiated carcinomas was an insular variant. All results are summarized in Table 1 .
All samples were processed as described by Kim et al. (4) and Piatyszek et al. (11) , with some modifications (8) . Briefly, 40 cryostat sections of 5-m thickness from each frozen block (corresponding to approximately 50 mg of tissue) were collected in Kontes homogenization tubes (4, 11) . Cryostat blades were changed for each tissue sample. Tissue sections were suspended in 200 L of ice-cold lysis buffer and were homogenized.
Protein concentrations were determined by the Bradford assay (BioRad) by using BSA as internal control.
Telomerase (TRAP) assay
The procedure was similar to that described by Kim et al. (4) and Piatyszek et al. (11) , slightly modified as already published (8) . Briefly, step 1 consisted of extension of a telomerase substrate (TS) oligomer (5ЈAATCCGTCGAGCAGAGTT-3Ј), and step 2 consisted of a hot-start PCR amplification of the product using a reverse CX primer [5Ј-(CCCTTA) 3 
Two to 4 L of CHAPS extracts (6 g of protein) were tested in a PCR tube in 50 L of a reaction buffer containing 68 mmol/L Kcl, 1. The tube was incubated 30 min at 23 C to allow for the extension of the TS primer by the telomerase. After elongation, the sample was heated at 94 C for 3 min. The PCR assay consisted of 30 cycles of 94 C for 30 sec, 50 C for 30 sec, and 72 C for 45 sec. Controls were included in each assay, as already described (8) PCR amplification products were analyzed on 10% polyacrylamide gel exposed directly to an autoradiographic film (Kodak, X-OMAT, Rochester, NJ) using intensifying screens.
Alkaline phosphatase activity
The stability of alkaline phosphatase seems to be similar to that of telomerase (11) . Thus, this enzyme is a useful independent marker to determine the integrity of telomerase extracts. We investigated the activity of alkaline phosphatase on frozen sections obtained from TRAPpositive and TRAP-negative tumors. Frozen sections were briefly fixed in acetone for 5 min and then incubated with a solution of New fuschin chromogen (Sigma, France) to reveal the activity of the enzyme. A red precipitate was seen in endothelial cells of virtually all blood vessels, and this signal could be abolished by a 15-min incubation with a solution of levamisole (1 mg in 0.05 n Tris-HCl, pH 8.7).
Results
Results are detailed in Table 1 and shown in Fig. 1 . Telomerase activity was not detected in normal thyroid tissues (0/20). Three of 15 cases (20%) of papillary carcinomas were positive for the TRAP assay. None of the two cases of papillary carcinomas with Hü rthle cells were positive. There was no significant difference regarding the size or the differentiation of the tumors, when considering the results of the TRAP assay. Similarly, the presence of metastases could not be correlated to the detection of telomerase activity, because only 1 of the 4 papillary carcinomas with cervical lymph node involvement was TRAP-positive. Four of 6 cases of follicular carcinoma (66%) displayed detectable levels of telomerase activity. The intensity of the signal varied from one case to another. Two of 3 cases (66%) of undifferentiated carcinomas were positive for telomerase activity. The one case of the insular type was TRAP positive.
One case of microfollicular adenoma showed an intense telomerase activity (Fig. 1) , whereas all other cases, irrespective of their subtype, remained completely negative. The positive case had no particular morphological and clinical aspect.
It was difficult to establish a grade in telomerase activity, but this activity varied from case to case. For example, all cases were checked morphologically, and we observed slight differences in the density of cells, from one tumor to another, that may explain variations in telomerase activity. However, the density of tumor cells was similar, overall, in TRAPpositive and TRAP-negative cases within the same histological subtype.
We checked to verify that there was no display of telomerase inhibitors in TRAP-negative cases. It was possible to detect the activity from 10 cells of the TRAP-positive lymphoma cell line diluted in a background of 9990 cells from TRAP-negative thyroid tumors (dilution 1:1000; Fig. 2 ). There was no difference in the activity of alkaline phosphatase on frozen sections from TRAP-positive and TRAPnegative tumors.
Discussion
In this study, we failed to detect telomerase activity in normal thyroid epithelium. All tissue samples were checked morphologically for the absence of tumor cells and lymphoid infiltrates. The sensitivity of the TRAP assay allows us to detect the activity of 10 telomerase-positive cells in a background of 10 4 negative ones (8) . Thus, we can conclude that normal thyroid cells are probably devoid of telomerase activity.
The results provide some evidence that telomerase is activated during thyroid carcinogenesis. This is not surprising, because the vast majority of cancers exhibit telomerase activity (4). Our study, however, suggests that telomerase activation is much less frequent in thyroid tumors, overall, compared with other types of cancers, and that telomerase activity is rather infrequent in the papillary subtype. Telomerase activation was frequently noticed in follicular and undifferentiated carcinomas, which are commonly more aggressive than papillary carcinomas (10) . However, the numbers of the tumors tested here are small, and statements about the prevalence of telomerase activity in these cancers are difficult to make. Our data do not allow us to draw any definite conclusions, but we think that telomerase activity should be tested as a prognostic factor in thyroid cancers. We think that the detection of telomerase activity may be helpful in differentiating dystrophic thyroid lesions from carcinomas and may be extended to cytological smears obtained after fine-needle aspirates of thyroid nodules. So far, cytodiagnosis seems poorly reliable and may be enhanced by the investigation of telomerase activity in cell suspensions. Such a combination has been validated for detecting cancer cells in breast (9) and in bladder washings and urine (12) .
The finding of telomerase activity in one case of microfollicular adenoma is intriguing and raises important questions. First, this case was classified as microfollicular adenoma because it lacked morphological criteria of follicular carcinoma (10) . The activation of telomerase in this lesion may indicate that the tumor contains cells undergoing a malignant transformation. Further experiments based on tissue microdissection may give some clues for understanding thyroid carcinogenesis. A strategy of selective cell analysis, from different areas of a given tumor, looking for a heterogeneous pattern of telomerase activity may yield interesting information.
In conclusion, we found that telomerase is not activated in normal thyroid cells, compared with other normal tissues such as breast (13) . We observed that telomerase activity was more frequently associated with agressive thyroid tumors of follicular and undifferentiated subtypes than with papillary carcinomas. The finding of telomerase activity in one case of microfollicular adenoma opens the question as to whether some adenomas may contain dysplastic or malignant cell subpopulation.
FIG. 2.
Results of the TRAP assay in a case of telomerase-negative papillary carcinoma after serial dilutions of protein extracts from the Ishikawa cell line. After serial dilutions, the signal is still visible at the dilution 1:1000. Lane R, RNase A predigestion of protein extracts from a case of TRAP-positive undifferentiated (insular) carcinoma (case lane 15 in Fig. 1 ); line N, negative control without protein extracts.
